Vlad Coric - Dec 31, 2021 Form 5 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role: Chief Executive Officer, Director
Signature: /s/ George Clark, Attorney-in-Fact
Stock symbol: BHVN
Transactions as of: Dec 31, 2021
Transactions value $: $0
Form type: 5
Date filed: 2/11/2022, 08:15 PM
Previous filing: Nov 26, 2021
Next filing: Jan 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Gift	$0	-29.8K	-29.78%	$0.00	70.2K	Jun 21, 2021	By The Vladimir Coric GRAT - 2019
transaction	BHVN	Common Shares	Gift	$0	+29.8K	+116.47%	$0.00	55.4K	Jun 21, 2021	Direct
transaction	BHVN	Common Shares	Gift	$0	-17.5K	-3.72%	$0.00	453K	Nov 26, 2021	By: The Vladimir Coric Family Trust	F1
transaction	BHVN	Common Shares	Gift	$0	-17.5K	-5.29%	$0.00	314K	Nov 26, 2021	By The Vladimir Coric Marital Trust	F1
holding	BHVN	Common Shares						19.1K	Dec 31, 2021	By 401(K) Plan

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in a trust for the benefit of the reporting person's family members, excluding the reporting person. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the reporting person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

These shares are held in a trust for the benefit of the reporting person's family members, excluding the reporting person. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the reporting person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.